Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -84.38% | 7.74% | -162.34% | -144.79% | -147.76% |
| Total Depreciation and Amortization | -0.53% | -4.60% | -27.04% | -23.15% | -19.66% |
| Total Amortization of Deferred Charges | 31.68% | -5.96% | -47.99% | -65.69% | -74.99% |
| Total Other Non-Cash Items | 617.83% | -7.52% | 105.70% | 103.95% | 103.27% |
| Change in Net Operating Assets | -26.75% | 14.92% | -67.45% | -71.88% | -83.45% |
| Cash from Operations | -4.66% | 22.93% | -3.37% | -7.28% | -5.28% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 74.26% | 22.55% | -61.27% | -67.50% | -76.13% |
| Cash from Investing | -85.83% | -64.79% | 36.85% | 16.10% | 8.06% |
| Total Debt Issued | 22.54% | 6.92% | -18.03% | -10.66% | -13.87% |
| Total Debt Repaid | -18.94% | -16.06% | 24.29% | 21.68% | 28.27% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 25.94% | -3.17% | -5.23% | 7.85% | 6.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -- | -- |